Scarica l'app Stockscreener
0.00
100.00%
-14.00
Dopo l'orario di chiusura:
13.99
13.99
+
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VTYX Giù?
Forum
Previsione
Precedente Chiudi:
$14.00
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$1.00B
Reddito:
-
Utile/perdita netta:
$-106.61M
Rapporto P/E:
0.00
EPS:
-1.4995
Flusso di cassa netto:
$-87.87M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Nome
Ventyx Biosciences Inc
Settore
Industria
Telefono
(760) 407-6511
Indirizzo
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
0.00 | 1.00B | 0 | -106.61M | -87.87M | -1.4995 |
VRTX
Vertex Pharmaceuticals Inc
|
447.26 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
777.25 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
743.12 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.73 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.86 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-05 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Downgrade | Stifel | Buy → Hold |
| 2023-11-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-03-21 | Iniziato | Wells Fargo | Overweight |
| 2022-12-19 | Iniziato | Goldman | Buy |
| 2022-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-07 | Iniziato | Stifel | Buy |
| 2022-09-01 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-09 | Iniziato | Credit Suisse | Outperform |
| 2022-03-31 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-15 | Iniziato | Jefferies | Buy |
| 2021-11-15 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Ventyx Biosciences Inc Borsa (VTYX) Ultime notizie
Will Ventyx Biosciences Inc stock hit new highs in YEAR2026 Stock Rankings & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Aug Decliners: Is Ventyx Biosciences Inc forming a double bottomStop Loss & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Published on: 2026-03-27 07:56:14 - baoquankhu1.vn
Ventyx Biosciences stock faces uncertainty after pipeline setback and strategic review - AD HOC NEWS
If You Invested $1,000 in Ventyx Biosciences, Inc. (VTYX) - stocktitan.net
Market Fear: How does Ventyx Biosciences Inc score in quality rankings2026 Trading Recap & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Aug PostEarnings: Can Ventyx Biosciences Inc benefit from deglobalizationEarnings Trend Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Aug Swings: Is Ventyx Biosciences Inc stock forming a triangle pattern2026 Stock Rankings & Capital Efficient Trading Techniques - baoquankhu1.vn
[15-12G] Ventyx Biosciences, Inc. SEC Filing - Stock Titan
LifeSci Capital downgrades Ventyx Biosciences (VTYX) - MSN
Growth Recap: Does Ventyx Biosciences Inc stock reflect fundamentalsWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Breakout Move: Is Ventyx Biosciences Inc stock overvalued or fairly priced2026 Update & Consistent Profit Trading Strategies - baoquankhu1.vn
[EFFECT] Ventyx Biosciences, Inc. SEC Filing - stocktitan.net
Ventyx Biosciences Stock: Retail Buzz Spikes After Phase 2 Win In Obesity And Heart Risk Study - MSN
Ventyx Biosciences (NASDAQ:VTYX) Upgraded to Hold at Wall Street Zen - MarketBeat
Why Ventyx Biosciences Inc. stock is rated strong buyJuly 2025 Weekly Recap & High Return Trade Guides - Naître et grandir
Lilly nearing $1 billion deal with biotech Ventyx, WSJ says - MSN
Assessing Ventyx Biosciences (VTYX) Valuation After A Sharp 90 Day Share Price Rebound - simplywall.st
Eli Lilly buys Ventyx (VTYX) in all-cash $14 per share merger - Stock Titan
Ventyx Biosciences Completes Cash Merger and Equity Payout - theglobeandmail.com
Ventyx Biosciences, Inc.(NasdaqGS:VTYX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Ventyx Biosciences (VTYX) exec records option dispositions in $14 Lilly buyout - Stock Titan
Ventyx Biosciences (VTYX) cashed out at $14 per share in Eli Lilly merger - Stock Titan
COO’s Ventyx (VTYX) options cashed out as Eli Lilly merger closes - Stock Titan
Lilly–Ventyx (VTYX) merger cancels director stock options at $14 - Stock Titan
Ventyx Biosciences (VTYX) director’s options cancelled in Eli Lilly cash merger - Stock Titan
Ventyx (VTYX) director’s options and shares cashed out at $14 in Eli Lilly merger - Stock Titan
Eli Lilly deal converts Ventyx (VTYX) CMO’s shares and options to cash - Stock Titan
Eli Lilly and Company completed the acquisition of Ventyx Biosciences, Inc. from New Science Ventures, LLC, Affinity Asset Advisors, LLC, The Vanguard Group, Inc., and others. - marketscreener.com
Ventyx Biosciences (VTYX) deregisters registered resale shares after merger - Stock Titan
Ventyx Biosciences (NASDAQ: VTYX) deregisters shares after Eli Lilly merger - Stock Titan
Ventyx Biosciences completes $1.2 billion acquisition by Eli Lilly, delists from Nasdaq - Investing.com India
Ventyx Biosciences (VTYX) notifies Nasdaq of common stock delisting - Stock Titan
Ventyx Biosciences Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Ventyx Biosciences (NASDAQ: VTYX) shareholders get $14 cash in Eli Lilly buyout - Stock Titan
Ventyx (VTYX) CEO cashes out stock and options in $14 Eli Lilly merger - stocktitan.net
VTYX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ventyx Biosciences, Inc.(VTYX) Shareholders - ACCESS Newswire
Ventyx Biosciences Shareholders Approve Merger With Eli Lilly - TipRanks
Ventyx Biosciences, Inc.(NasdaqGS: VTYX) dropped from NASDAQ Composite Index - marketscreener.com
Ventyx Biosciences shareholders approve merger with Eli Lilly By Investing.com - Investing.com South Africa
Ventyx Biosciences shareholders approve merger with Eli Lilly - Investing.com Nigeria
Ventyx Biosciences (VTYX) investors approve Eli Lilly merger and executive pay - Stock Titan
Insider Sell: Is Skyward Specialty Insurance Group Inc attractive at current valuationWeekly Trend Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
VTYX Should I Buy - Intellectia AI
Ventyx Biosciences Inc. (VTYX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Best Pharmaceutical Stocks To Follow NowFebruary 27th - MarketBeat
Ventyx Biosciences (NASDAQ:VTYX) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
GLAZER CAPITAL, LLC Acquires Significant Stake in Ventyx Bioscie - GuruFocus
Ventyx Faces Eli Lilly Acquisition, Delisting and Litigation - TipRanks
Ventyx Biosciences agrees to $14.00 cash per share merger with Eli Lilly; HSR waiting period cleared - TradingView
Ventyx Biosciences Inc Azioni (VTYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.52%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):